Mednet Logo
HomeNeurology
Neurology

Neurology

Expert perspectives on neurological conditions, stroke management, movement disorders, and neuromuscular disease.

Recent Discussions

How do you decide when to extend rituximab redosing beyond a 6 month interval for replasing multiple sclerosis?

1
2 Answers

Mednet Member
Mednet Member
Neurology · UTHealth

In light of the published study, the discussion that I've had with patients revolves around utilizing CD19/CD20 counts to guide infusion frequency.

How would you empirically manage a large sellar/suprasellar mass with encasement of the right cavernous and terminal internal carotid arteries?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Arizona

Knowing the histology of the mass would really help in creating more accurate treatment recommendations. A biopsy of a sellar mass is usually accomplished by an endonasal-endoscopic trans-sphenoidal approach utilizing the expertise of an ENT surgeon and a skull-base neurosurgeon. However, in this ca...

Should aTTR mutation with bilateral carpal tunnel alone prompt treatment with a gene silencing drug?

1
1 Answers

Mednet Member
Mednet Member
Neurology · Cedars-Sinai Medical Center

Carpal Tunnel Syndrome does not qualify as a peripheral neuropathy due to TTR amyloid. The amyloid deposition is in the soft and/or connective tissue and not in the nerve. As such, there is no clear indication to treat as much as one might be tempted. Careful follow-up and treatment as soon as neuro...

At what lab values (ferritin, TSAT%) would you offer IV iron therapy to patients with restless leg syndrome?

4
2 Answers

Mednet Member
Mednet Member
Hematology · Georgetown University School of Medicine

1. I am hopeful that practitioners will start understanding that ferritin alone is not enough to assess iron because of its acute phase reactivity. I like to order iron parameters after a 5-9 hour fast so the serum iron is not speciously elevated and get a ferritin and TSAT. If the ferritin is <30 a...

How do you approach treatment of a glioblastoma in pregnancy?

2
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Louisville School of Medicine

Glioblastoma during pregnancy could be treated safely (to mother and fetus) with certain precautions and modifications. Collaboration and consultation with the patient’s obstetrician are essential. External shielding over the patient’s abdomen during treatment will decrease the external scatter radi...

What are your preferred second-line medications for trigeminal neuralgia?

1
4 Answers

Mednet Member
Mednet Member
Neurology · UPMC

My first line is oxcarbazepine or carbamazepine. The second line is gabapentin. Then, in no particular order, baclofen and lamotrigine. Other options to try: pimozide, tizanidine, phenytoin, valproic acid. If 1 agent does not provide good control, I refer to a surgeon as we try a 2nd agent.

Do you wait to treat small asymptomatic brain metastases until they reach a certain size?

4
4 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Wisconsin Hospital & Clinics

I typically treat all lesions on MRI that are found to be concerning for brain metastases. This is after a discussion with our neuroradiologist colleagues. If there is uncertainty that a small lesion may not be a brain metastasis, then I will elect to follow with a surveillance MRI and treat in the ...

How do you determine the timeline for healing after craniotomy prior to starting chemotherapy and radiation?

2
4 Answers

Mednet Member
Mednet Member
Radiation Oncology · UMass Memorial Medical Group

I typically wait at least 10-14 days post-op, always after neurosurgery has re-evaluated the craniotomy site for appropriate healing and has already removed staples or sutures.

How do you counsel patients and caregivers about the trajectory of cognitive decline in Parkinson’s disease?

1
2 Answers

Mednet Member
Mednet Member
Neurology · Keck School of Medicine of USC

I address the subject of cognitive impairment fairly early in PD, since patients may notice mild deficits in multitasking and attention even within the first few years of diagnosis. Strategies such as making lists and breaking down individual tasks are effective in preserving independence. Worsening...

For a patient with acute stroke who cannot tolerate statins, what is your preferred second-line agent for secondary prevention?

1 Answers

Mednet Member
Mednet Member
Hospital Medicine · Northwestern Memorial Hospital

First question - is the patient experiencing the nocebo effect? I would explore statin-based symptoms. Ezetimibe - if only needs a small reduction. If you need to be more aggressive, I would use PCSK9 inhibitors. If the patient cannot tolerate a PCSK9 inhibitor or if you need more lowering, you can ...